|
|
|
|
LEADER |
01204nam a2200265 u 4500 |
001 |
EB000943017 |
003 |
EBX01000000000000000736607 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
245 |
0 |
0 |
|a Human immunodeficiency virus (HIV) testing for pregnant women
|h Elektronische Ressource
|b final report
|c produced by the Health Technology Advisory Committee
|
260 |
|
|
|a St. Paul, Minn.
|b Health Technology Advisory Committee, Minnesota Health Care Commission
|c [1997], 1997
|
300 |
|
|
|a ii, 38 p.
|c 28 cm
|
505 |
0 |
|
|a Includes bibliographical references (p. 37-38)
|
653 |
|
|
|a Mass Screening
|
653 |
|
|
|a Infectious Disease Transmission, Vertical / prevention & control
|
653 |
|
|
|a Pregnancy
|
653 |
|
|
|a Infant, Newborn, Diseases / prevention & control
|
653 |
|
|
|a HIV Infections / diagnosis
|
710 |
2 |
|
|a Minnesota
|b Health Technology Advisory Committee
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
500 |
|
|
|a "Approved by the Minnesota Health Care Commission June 18, 1997."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK52496
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|